The benefit of adjuvant hysterectomy after definitive concurrent chemoradiotherapy (CCRT)
for locally‑advanced cervical cancer (LACC) is controversial. The purpose of the present …

5005 Background: Adjuvant platinum based radiochemotherapy in high-risk cervical cancer
is an established treatment strategy to improve overall survival. Based on several trials for …

Background: The standard treatment for locally advanced cervical cancer is CTRT. We
tested in a RCT whether outcomes could be improved by NACT-surgery. Methods: Patients …

Background: Randomized studies comparing induction chemotherapy followed by surgical
resection with radiation alone found that the neoadjuvant approach produces better results …

OBJECTIVE: To compare the long-term clinical outcomes of adjuvant radiotherapy (RT)
versus concurrent chemoradiotherapy (CCRT) in cervical cancer patients with intermediate …

PURPOSE: Neoadjuvant chemotherapy (NACT) and radical surgery (RS) have emerged as
a possible alternative to conventional radiation therapy (RT) in locally advanced cervical …

Concurrent cisplatin-based chemotherapy and radiotherapy (CCRT) plus brachytherapy is
standard treatment for locally advanced cervical cancer. Platinum-based neoadjuvant …

Background Current standard treatment for patients with cervical cancer who have locally
advanced stage disease (International Federation of Gynecology and Obstetrics (FIGO) …

Background and Methods On behalf of the Gynecologic Oncology Group, we performed a
randomized trial of radiotherapy in combination with three concurrent chemotherapy …

Objective To evaluate the outcomes and the prognostic factors for advanced squamous
cervical cancer after concurrent chemoradiotherapy (CCRT). Methods Totally 172 patients …